Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew S Miller

Showing results (101-110 of 111) with videos related to

Pageof 12
Sort By:
Microbiology Spectrum|January 12, 2024
Risk factors for recognized and unrecognized SARS-CoV-2 infection: a seroepidemiologic analysis of the Prospective Urban Rural Epidemiology (PURE) studyDarryl P Leong, Mark Loeb, Prem K Mony, et al.
The European Respiratory Journal|January 21, 2022
Cigarette smoke augments CSF3 expression in neutrophils to compromise alveolar-capillary barrier function during influenza infectionJoshua J C McGrath, Gilles Vanderstocken, Anna Dvorkin-Gheva, et al.
The European Respiratory Journal|July 18, 2020
Gene expression and <i>in situ</i> protein profiling of candidate SARS-CoV-2 receptors in human airway epithelial cells and lung tissueJennifer A Aguiar, Benjamin J-M Tremblay, Michael J Mansfield, et al.
Viruses|November 27, 2021
Lasting Changes to Circulating Leukocytes in People with Mild SARS-CoV-2 InfectionsAllison E Kennedy, Laura Cook, Jessica A Breznik, et al.
Nature Communications|July 2, 2025
Induction of lung mucosal immunity by a next-generation inhaled aerosol COVID-19 vaccine: an open-label, multi-arm phase 1 clinical trialMangalakumari Jeyanathan, Sam Afkhami, Michael R D'Agostino, et al.
Emerging Infectious Diseases|June 12, 2023
Sensitivity to Neutralizing Antibodies and Resistance to Type I Interferons in SARS-CoV-2 R.1 Lineage Variants, CanadaRajesh Abraham Jacob, Ali Zhang, Hannah O Ajoge, et al.
Iscience|May 3, 2021
Experimental and natural evidence of SARS-CoV-2-infection-induced activation of type I interferon responsesArinjay Banerjee, Nader El-Sayes, Patrick Budylowski, et al.
Cell|February 18, 2022
Respiratory mucosal delivery of next-generation COVID-19 vaccine provides robust protection against both ancestral and variant strains of SARS-CoV-2Sam Afkhami, Michael R D'Agostino, Ali Zhang, et al.
Cell Reports. Medicine|October 5, 2020
Cross-Sectional Evaluation of Humoral Responses against SARS-CoV-2 SpikeJérémie Prévost, Romain Gasser, Guillaume Beaudoin-Bussières, et al.
Biorxiv : the Preprint Server for Biology|June 25, 2020
Cross-sectional evaluation of humoral responses against SARS-CoV-2 SpikeJérémie Prévost, Romain Gasser, Guillaume Beaudoin-Bussières, et al.
Pageof 12

Showing results (101-110 of 111) with videos related to

Sort By:
Pageof 12
Microbiology Spectrum|January 12, 2024
Risk factors for recognized and unrecognized SARS-CoV-2 infection: a seroepidemiologic analysis of the Prospective Urban Rural Epidemiology (PURE) studyDarryl P Leong, Mark Loeb, Prem K Mony, et al.
The European Respiratory Journal|January 21, 2022
Cigarette smoke augments CSF3 expression in neutrophils to compromise alveolar-capillary barrier function during influenza infectionJoshua J C McGrath, Gilles Vanderstocken, Anna Dvorkin-Gheva, et al.
The European Respiratory Journal|July 18, 2020
Gene expression and <i>in situ</i> protein profiling of candidate SARS-CoV-2 receptors in human airway epithelial cells and lung tissueJennifer A Aguiar, Benjamin J-M Tremblay, Michael J Mansfield, et al.
Viruses|November 27, 2021
Lasting Changes to Circulating Leukocytes in People with Mild SARS-CoV-2 InfectionsAllison E Kennedy, Laura Cook, Jessica A Breznik, et al.
Nature Communications|July 2, 2025
Induction of lung mucosal immunity by a next-generation inhaled aerosol COVID-19 vaccine: an open-label, multi-arm phase 1 clinical trialMangalakumari Jeyanathan, Sam Afkhami, Michael R D'Agostino, et al.
Emerging Infectious Diseases|June 12, 2023
Sensitivity to Neutralizing Antibodies and Resistance to Type I Interferons in SARS-CoV-2 R.1 Lineage Variants, CanadaRajesh Abraham Jacob, Ali Zhang, Hannah O Ajoge, et al.
Iscience|May 3, 2021
Experimental and natural evidence of SARS-CoV-2-infection-induced activation of type I interferon responsesArinjay Banerjee, Nader El-Sayes, Patrick Budylowski, et al.
Cell|February 18, 2022
Respiratory mucosal delivery of next-generation COVID-19 vaccine provides robust protection against both ancestral and variant strains of SARS-CoV-2Sam Afkhami, Michael R D'Agostino, Ali Zhang, et al.
Cell Reports. Medicine|October 5, 2020
Cross-Sectional Evaluation of Humoral Responses against SARS-CoV-2 SpikeJérémie Prévost, Romain Gasser, Guillaume Beaudoin-Bussières, et al.
Biorxiv : the Preprint Server for Biology|June 25, 2020
Cross-sectional evaluation of humoral responses against SARS-CoV-2 SpikeJérémie Prévost, Romain Gasser, Guillaume Beaudoin-Bussières, et al.
Pageof 12